Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism

Clinical and Applied Thrombosis/Hemostasis - United States
doi 10.1177/1076029618758955
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Journal of Vascular Surgery: Venous and Lymphatic Disorders
SurgeryCardiovascular MedicineCardiology
2017English

Rivaroxaban Versus Warfarin Treatment Among Morbidly Obese Patients With Venous Thromboembolism: Comparative Effectiveness, Safety, and Costs

Thrombosis Research
Hematology
2019English

Venous Thromboembolism Prophylaxis After TKA: Aspirin, Warfarin, Enoxaparin, or Factor Xa Inhibitors?

Clinical Orthopaedics and Related Research
MedicineSurgeryOrthopedicsSports MedicineSports Science
2017English

Long-Term Rivaroxaban for the Treatment of Acute Venous Thromboembolism in Patients With Active Cancer in a Prospective Multicenter Trial

Korean Journal of Internal Medicine
Internal Medicine
2019English

Pcv138 - Treatment Patterns of Patients With Venous Thromboembolism Treated With Oral Anticoagulants in England

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Treating Venous Thromboembolism in Patients With Cancer

Expert Review of Hematology
Hematology
2012English

Symptomatic Venous Thromboembolism After Non-Operatively Treated Foot or Ankle Injury

Journal of Orthopaedic Research
OrthopedicsSports Medicine
2018English

Primary Prophylaxis for Venous Thromboembolism in Patients Undergoing Cardiac or Thoracic Surgery

Cochrane Database of Systematic Reviews
2015English

Ethnicity of Patients With Venous Thromboembolism

Circulation Journal
MedicineCardiovascular MedicineCardiology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy